NPI: 1427064310 · NEWPORT NEWS, VA 23602 · General Acute Care Hospital · NPI assigned 07/31/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR PAYOR ADMIN) |
| NPI Enumeration Date | 07/31/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 75,776 | $1.84M |
| 2019 | 107,872 | $2.71M |
| 2020 | 89,473 | $2.92M |
| 2021 | 123,148 | $3.95M |
| 2022 | 122,223 | $4.36M |
| 2023 | 132,233 | $4.50M |
| 2024 | 93,181 | $4.23M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 32,905 | 27,692 | $4.98M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 24,076 | 20,217 | $4.04M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14,961 | 12,518 | $2.59M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,732 | 6,270 | $2.14M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10,108 | 8,436 | $1.32M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,505 | 3,942 | $1.03M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 22,187 | 5,554 | $872K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 16,873 | 4,917 | $798K |
| 59025 | Fetal non-stress test | 5,315 | 3,458 | $796K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,876 | 3,351 | $683K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,321 | 3,626 | $376K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,596 | 2,247 | $358K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,327 | 962 | $341K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,653 | 1,407 | $325K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,423 | 1,253 | $312K |
| 93975 | 2,444 | 2,125 | $247K | |
| G0378 | Hospital observation service, per hour | 2,058 | 1,187 | $230K |
| 74240 | 2,177 | 2,004 | $227K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,283 | 2,027 | $187K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,053 | 2,003 | $186K |
| 97162 | 1,669 | 1,524 | $182K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,335 | 3,698 | $178K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,022 | 458 | $175K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 14,226 | 3,845 | $164K |
| 97161 | 1,812 | 1,593 | $155K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 22,059 | 17,310 | $138K |
| 80053 | Comprehensive metabolic panel | 30,768 | 24,638 | $117K |
| 97535 | Self-care/home management training, each 15 minutes | 4,174 | 2,266 | $107K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 909 | 811 | $95K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 672 | 478 | $91K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,789 | 3,529 | $84K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,406 | 1,200 | $54K |
| 93971 | 636 | 550 | $52K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 155 | 141 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,885 | 1,662 | $46K |
| 97016 | 1,826 | 497 | $42K | |
| C1776 | Joint device (implantable) | 345 | 268 | $40K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,893 | 4,324 | $40K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 971 | 914 | $37K |
| 97116 | 1,670 | 926 | $36K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,220 | 7,664 | $36K |
| 83880 | 2,934 | 2,471 | $25K | |
| 97602 | 164 | 51 | $25K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,309 | 1,063 | $23K |
| 71046 | Radiologic examination, chest; 2 views | 7,349 | 6,579 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 36,529 | 28,930 | $22K |
| 76830 | Ultrasound, transvaginal | 366 | 320 | $20K |
| 87040 | 2,638 | 1,391 | $17K | |
| 36415 | Collection of venous blood by venipuncture | 13,040 | 9,565 | $15K |
| 82553 | 6,666 | 4,660 | $14K | |
| 71045 | Radiologic examination, chest; single view | 11,007 | 9,156 | $14K |
| 86850 | 4,693 | 3,929 | $14K | |
| 49083 | 27 | 16 | $14K | |
| 97165 | 253 | 197 | $13K | |
| 80076 | 2,619 | 2,345 | $13K | |
| 0346T | 218 | 189 | $12K | |
| 85379 | 2,678 | 2,318 | $12K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 15,906 | 12,030 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | 282 | 248 | $10K |
| 76942 | 211 | 190 | $10K | |
| 84484 | 14,256 | 9,194 | $10K | |
| 93970 | 70 | 66 | $10K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,971 | 2,809 | $10K |
| 82107 | 432 | 402 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,138 | 13,294 | $8K |
| 85027 | 3,571 | 2,776 | $8K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 848 | 703 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,803 | 4,239 | $7K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,387 | 506 | $7K |
| 85610 | 4,932 | 4,015 | $7K | |
| 84703 | 4,921 | 4,220 | $5K | |
| 86900 | 5,445 | 4,600 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,949 | 1,679 | $5K |
| 85014 | 1,183 | 983 | $5K | |
| 88307 | 459 | 365 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 13,227 | 10,618 | $5K |
| 87521 | Neg quan hep c or qual rna | 276 | 238 | $5K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,305 | 5,821 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4,618 | 4,158 | $4K |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,796 | 2,958 | $4K |
| 87641 | 413 | 355 | $4K | |
| 82728 | 688 | 630 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,221 | 8,215 | $4K |
| J3490 | Unclassified drugs | 10,399 | 5,728 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,061 | 1,692 | $4K |
| 81025 | 13,268 | 11,317 | $4K | |
| 81001 | 16,736 | 14,044 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 14,135 | 8,125 | $3K |
| 73630 | 923 | 834 | $3K | |
| 82962 | 8,993 | 4,287 | $3K | |
| 93976 | 53 | 47 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,136 | 5,175 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | 12,291 | 9,635 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,671 | 1,477 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,875 | 5,042 | $3K |
| 86901 | 5,442 | 4,599 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 332 | 262 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 770 | 684 | $3K |
| 83540 | 830 | 745 | $3K | |
| 83605 | 2,533 | 1,966 | $2K | |
| 90715 | 141 | 134 | $2K | |
| 83735 | 8,485 | 6,554 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,424 | 1,980 | $2K |
| 81003 | 11,624 | 9,594 | $2K | |
| 80143 | 386 | 333 | $2K | |
| 80179 | 374 | 321 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,708 | 2,174 | $2K |
| 74018 | 788 | 708 | $2K | |
| 72110 | 192 | 174 | $2K | |
| 83690 | 11,524 | 9,487 | $2K | |
| 96376 | 3,683 | 2,185 | $2K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 320 | 262 | $2K |
| 84702 | 2,909 | 2,289 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,304 | 2,639 | $2K |
| 99218 | 149 | 118 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,229 | 3,647 | $1K |
| 85018 | 1,109 | 920 | $1K | |
| 73610 | 625 | 555 | $1K | |
| 82550 | 7,281 | 5,169 | $1K | |
| 85730 | 2,712 | 2,219 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,135 | 2,348 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,108 | 851 | $1K |
| 73130 | 369 | 319 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,681 | 4,138 | $996.02 |
| J2060 | Injection, lorazepam, 2 mg | 613 | 483 | $983.67 |
| 82607 | 132 | 129 | $967.20 | |
| 73030 | 408 | 354 | $922.82 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,405 | 1,964 | $906.84 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 8,491 | 5,701 | $879.18 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,615 | 6,553 | $866.77 |
| 82731 | 42 | 36 | $762.86 | |
| 73564 | 535 | 457 | $725.09 | |
| 80050 | General health panel | 142 | 132 | $704.18 |
| 82077 | 2,150 | 1,786 | $700.24 | |
| 87070 | 4,239 | 3,679 | $680.58 | |
| 87210 | 3,840 | 3,368 | $624.06 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 372 | 330 | $613.58 |
| 87077 | 2,126 | 1,754 | $584.86 | |
| 84439 | 146 | 133 | $528.45 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,689 | 4,430 | $492.20 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 16 | 12 | $441.68 |
| 87081 | 1,010 | 915 | $395.80 | |
| C9399 | Unclassified drugs or biologicals | 70 | 55 | $383.48 |
| 84112 | 77 | 61 | $380.93 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,381 | 2,894 | $367.95 |
| 86704 | 59 | 51 | $359.24 | |
| 82746 | 95 | 93 | $351.22 | |
| 74022 | 188 | 157 | $332.08 | |
| 87186 | 1,836 | 1,499 | $315.57 | |
| 84425 | 26 | 26 | $314.14 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 28 | 26 | $313.65 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 90 | 78 | $309.61 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,289 | 916 | $299.71 |
| 87807 | 587 | 564 | $288.11 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 151 | 146 | $284.82 |
| 85652 | 292 | 259 | $280.50 | |
| 86708 | 73 | 63 | $279.31 | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,003 | 663 | $272.87 |
| 86706 | 74 | 64 | $260.50 | |
| 74220 | 15 | 12 | $254.12 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 767 | 604 | $230.32 |
| 80061 | Lipid panel | 63 | 51 | $230.30 |
| 83550 | 76 | 63 | $228.33 | |
| 73562 | 304 | 260 | $223.28 | |
| 87340 | 70 | 60 | $206.43 | |
| 90686 | 16 | 14 | $198.82 | |
| 97166 | 15 | 12 | $195.24 | |
| 94762 | 194 | 172 | $153.37 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 13 | 12 | $147.93 |
| 0100U | 40 | 27 | $142.42 | |
| 86677 | 18 | 14 | $133.27 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,476 | 1,154 | $131.64 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 611 | 478 | $120.89 |
| 76981 | 273 | 246 | $113.82 | |
| J1815 | Injection, insulin, per 5 units | 42 | 26 | $106.72 |
| 73502 | 15 | 12 | $89.30 | |
| 80047 | 12 | 12 | $85.41 | |
| J2704 | Injection, propofol, 10 mg | 7,426 | 5,268 | $83.87 |
| 84132 | 70 | 54 | $78.84 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 777 | 348 | $72.73 |
| 84550 | 105 | 79 | $69.25 | |
| J1644 | Injection, heparin sodium, per 1000 units | 839 | 376 | $67.61 |
| 88304 | 22 | 18 | $63.12 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 825 | 673 | $62.70 |
| 87147 | 806 | 546 | $47.82 | |
| 82140 | 17 | 14 | $41.29 | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,733 | 1,123 | $36.87 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 732 | 542 | $32.21 |
| 87205 | 168 | 139 | $31.54 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 706 | 586 | $30.78 |
| 73090 | 13 | 12 | $29.63 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 504 | 423 | $26.80 |
| 87088 | 58 | 57 | $19.60 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 284 | 206 | $14.85 |
| J7510 | Prednisolone oral, per 5 mg | 86 | 81 | $13.42 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 312 | 235 | $11.23 |
| 82570 | 35 | 26 | $6.01 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 126 | 115 | $5.57 |
| J1790 | Injection, droperidol, up to 5 mg | 217 | 182 | $4.87 |
| 84156 | 57 | 36 | $2.68 | |
| 83615 | 16 | 12 | $2.68 | |
| C1769 | Guide wire | 126 | 104 | $2.50 |
| J3360 | Injection, diazepam, up to 5 mg | 35 | 27 | $0.54 |
| 73110 | 95 | 62 | $0.00 | |
| 99152 | 18 | 13 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 288 | 253 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 428 | 343 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 173 | 148 | $0.00 |
| C1729 | Catheter, drainage | 24 | 14 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 82 | 79 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 123 | 58 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 55 | 26 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 114 | 94 | $0.00 |
| 96367 | 15 | 13 | $0.00 | |
| A4641 | Radiopharmaceutical, diagnostic, not otherwise classified | 13 | 12 | $0.00 |
| 89051 | 62 | 26 | $0.00 | |
| 88313 | 13 | 13 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 356 | 294 | $0.00 |
| A9270 | Non-covered item or service | 1,039 | 346 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 16 | 15 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 222 | 172 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 540 | 382 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 127 | 91 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 291 | 260 | $0.00 |
| 82803 | 92 | 73 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 25 | 12 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 74 | 66 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 86 | 65 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 40 | 40 | $0.00 |
| 94760 | 67 | 56 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 13 | 12 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 189 | 183 | $0.00 |